"Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R)"
Zepbound (tirzepatide) injection drug label, Food and Drug Administration (2024) Kaiser Permanente Northwest region criteria for drug coverage tirzepatide (Zepbound), Kaiser Foundation Health Plan of the Northwest (2025) Kaiser Permanente Insurance Company (KPIC) point-of-service (POS) drug formulary, Kaiser Permanente Insurance Company (2025) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) How much should I expect to pay for Zepbound (tirzepatide)?, Lilly (2024) Prescription drug cost lookup, Kaiser Permanente Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Although all evaluated GLP-1RAs were associated with lower odds of SUD outcomes, the magnitude of association varied across some agents
Preparation of PEG-PLA NPs PEG-PLA was prepared as previously reported
For studies requiring sustained peptide exposure, twice-daily dosing maintains more consistent plasma levels than single daily administration
These precautions help ensure the medication is used safely and effectively
